GlaxoSmithKline PharmaceuticalsGLAXO 
$26.59-0.80%24h
-0.80%24h
Global rank2868
Market cap$4.51B
Change 7d0.40%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of January 2025, GlaxoSmithKline Pharmaceuticals has a market cap of $4.51B. This makes GlaxoSmithKline Pharmaceuticals the world's 2868th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.38B | 15.89% |
| 2023 | $3.78B | 43.94% |
| 2022 | $2.62B | -24.93% |
| 2021 | $3.49B | 8.17% |
| 2020 | $3.23B | 0.85% |
| 2019 | $3.20B | 6.27% |
| 2018 | $3.01B | 21.75% |
| 2017 | $2.48B | -8.81% |
| 2016 | $2.72B | -17.63% |
| 2015 | $3.30B | 3.61% |
| 2014 | $3.18B | 6.68% |
| 2013 | $2.98B | 38.29% |
| 2012 | $2.16B | 11.46% |
| 2011 | $1.93B | -16.79% |
| 2010 | $2.33B | 45.01% |
| 2009 | $1.60B | 40.09% |
| 2008 | $1.14B | 12.02% |
| 2007 | $1.02B | -11.67% |
| 2006 | $1.16B | 3.67% |
| 2005 | $1.12B | 45.67% |
| 2004 | $765.97M | 34.30% |
| 2003 | $570.36M | 87.85% |
| 2002 | $303.63M | - |
GLAXO Market Cap Today is $4.51B -0.80% - 21 Jan 2025
View largest stocks by market cap 
